Feb 21, 2017 13:02 pm UTC| Business
PRINCETON JUNCTION, N.J., Feb. 21, 2017 -- The Smart Card Alliance Payments, Mobile and Transportation Councils had a successful year in 2016 with strong member participation, quality deliverables, and significant...
Qorvo® Introduces Industry’s Best Performing and Broadest RF Front End Portfolio for Power Class 2
Feb 21, 2017 13:02 pm UTC| Business
GREENSBORO, N.C., Feb. 21, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced a portfolio of RF front ends for LTE Power Class 2 – also known as high...
Bio-Path Holdings Appoints Dr. Craig Hooper to Scientific Advisory Board
Feb 21, 2017 13:02 pm UTC| Business
HOUSTON, Feb. 21, 2017 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid...
Feb 21, 2017 13:02 pm UTC| Business
PRINCETON JUNCTION, N.J., Feb. 21, 2017 -- The Smart Card Alliance Payments, Mobile and Transportation Councils had a successful year in 2016 with strong member participation, quality deliverables, and significant...
Feb 21, 2017 13:02 pm UTC| Business
PRINCETON JUNCTION, N.J., Feb. 21, 2017 -- The Smart Card Alliance Payments, Mobile and Transportation Councils had a successful year in 2016 with strong member participation, quality deliverables, and significant...
XBiotech Reports Affirmative Interim Analysis of Global Phase 3 Colorectal Cancer Study
Feb 21, 2017 13:02 pm UTC| Business
AUSTIN, Texas, Feb. 21, 2017 -- XBiotech Inc. (NASDAQ:XBIT) today announced that an Independent Data Monitoring Committee (IDMC) has performed a prospectively planned, unblinded analysis of the Phase 3 XCITE study for...
Bio-Path Holdings Appoints Dr. Craig Hooper to Scientific Advisory Board
Feb 21, 2017 13:02 pm UTC| Business
HOUSTON, Feb. 21, 2017 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid...
Trump Says Ukraine Peace Deal ‘Closer,’ But Key Disputes Remain Unresolved